SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT

N. Grun; C. A. den Otter; M. Sintemaartensdijk; J. Osinga; F. E. L. van den Elzen; A. N. van der Vegt; J. de Haan; A. M. E. Bruynzeel; M. E. van Linde; T. J. Postma; M. Schuur; P. C. de Witt Hamer; F. Y. F. L. De Vos; J. J. C. Verhoeff; J. L. M. Jongen; B. I. Lissenberg-Witte; M. C. M. Kouwenhoven

SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT

N. Grun, C. A. den Otter, M. Sintemaartensdijk, J. Osinga, F. E. L. van den Elzen, A. N. van der Vegt, J. de Haan, A. M. E. Bruynzeel, M. E. van Linde, T. J. Postma, M. Schuur, P. C. de Witt Hamer, F. Y. F. L. De Vos, J. J. C. Verhoeff, J. L. M. Jongen, B. I. Lissenberg-Witte, M. C. M. Kouwenhoven

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	40-40
Journal	Neuro-oncology
Volume	23
Publication status	Published - Sept 2021

Cite this

Grun, N., den Otter, C. A., Sintemaartensdijk, M., Osinga, J., van den Elzen, F. E. L., van der Vegt, A. N., de Haan, J., Bruynzeel, A. M. E., van Linde, M. E., Postma, T. J., Schuur, M., Hamer, P. C. D. W., De Vos, F. Y. F. L., Verhoeff, J. J. C., Jongen, J. L. M., Lissenberg-Witte, B. I., & Kouwenhoven, M. C. M. (2021). SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT. Neuro-oncology, 23, 40-40.

@article{760dac9dd9b640ed9116526bcc9bae70,

title = "SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT",

author = "N. Grun and {den Otter}, {C. A.} and M. Sintemaartensdijk and J. Osinga and {van den Elzen}, {F. E. L.} and {van der Vegt}, {A. N.} and {de Haan}, J. and Bruynzeel, {A. M. E.} and {van Linde}, {M. E.} and Postma, {T. J.} and M. Schuur and Hamer, {P. C. de Witt} and {De Vos}, {F. Y. F. L.} and Verhoeff, {J. J. C.} and Jongen, {J. L. M.} and Lissenberg-Witte, {B. I.} and Kouwenhoven, {M. C. M.}",

year = "2021",

month = sep,

language = "English",

volume = "23",

pages = "40--40",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

}

Grun, N, den Otter, CA, Sintemaartensdijk, M, Osinga, J, van den Elzen, FEL, van der Vegt, AN, de Haan, J, Bruynzeel, AME , van Linde, ME, Postma, TJ, Schuur, M, Hamer, PCDW, De Vos, FYFL, Verhoeff, JJC, Jongen, JLM, Lissenberg-Witte, BI & Kouwenhoven, MCM 2021, 'SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT', Neuro-oncology, vol. 23, pp. 40-40.

TY - JOUR

T1 - SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT

AU - Grun, N.

AU - den Otter, C. A.

AU - Sintemaartensdijk, M.

AU - Osinga, J.

AU - van den Elzen, F. E. L.

AU - van der Vegt, A. N.

AU - de Haan, J.

AU - Bruynzeel, A. M. E.

AU - van Linde, M. E.

AU - Postma, T. J.

AU - Schuur, M.

AU - Hamer, P. C. de Witt

AU - De Vos, F. Y. F. L.

AU - Verhoeff, J. J. C.

AU - Jongen, J. L. M.

AU - Lissenberg-Witte, B. I.

AU - Kouwenhoven, M. C. M.

PY - 2021/9

Y1 - 2021/9

M3 - Meeting Abstract

SN - 1522-8517

VL - 23

SP - 40

EP - 40

JO - Neuro-oncology

JF - Neuro-oncology

ER -